Global Allergy Diagnostics and Therapeutics Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028
“Global Allergy Diagnostics and Therapeutics Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global allergy diagnostics and therapeutics market report has been segmented on the basis of product, allergen type, test type, drug class, end user, and region.
Global Allergy Diagnostics and Therapeutics Market: Dynamics
Rapidly growing urbanization in developing countries, increasing Greenhouse Gas (GHG) concentrations, and increasing industrial pollution are major factors expected to drive growth of the global market over the forecast period.
In addition, increasing development of technologically advanced products such as MeDALL allergen-chip for allergy determination is further fuel growth of the target market over the forecast period.
Moreover, rising incidences of allergic condition, owing to poor dietary habits, increasing levels of pollution, changing lifestyle, and rapid urbanization across the globe which in turn is expected to propel growth of the target market over the forecast period.
However, high cost of equipment and lack of awareness regarding allergic diseases is a key factor expected to restrain growth of the global market over the forecast period.
Rising incidences of allergic conditions along with increasing adoption of immunoassay as diagnostic test are expected to create lucrative opportunities for the global market over the forecast period.
In addition, increasing research and development activities for the development of new and technologically advanced products are expected to create potential revenue opportunities for players operating in the target market over the forecast period.
Manufacturers operating in the target market are increasing their focus on improving their business and product offerings by strategic business activities such as mergers and acquisitions, which will further support growth of the global market over the forecast period.
Global Allergy Diagnostics and Therapeutics Market: Segment Analysis
Among the product segments, the instruments segment is expected to register highest CAGR over the forecast period, increasing demand for laminators and analyzers for allergy diagnostics.
Among the test type segments, the in vitro test segment is expected to register significant growth over the forecast period, owing to increasing demand for minimally invasive and allergen-specific tests.
Among the drug class type segments, the antihistamines drug class segment is expected to register highest growth over the forecast period, owing to its advantages, such as minimum side-effects and non-sedating nature.
Global Allergy Diagnostics and Therapeutics Market: Regional Analysis
The market in North America is expected to dominate into the global market in terms of revenue over the forecast period, owing to rising incidence of respiratory allergic disorders, increasing adoption of in-vitro blood tests, and rising awareness of allergy diagnostics across various countries in this region.
The market in Europe is expected register second-highest revenue share in the target market over the forecast period, owing to well-developed pharmaceutical industry, growing geriatric population, and rising demand for therapeutics across various countries in this region.
The market in Asia Pacific is expected to register significant growth in terms of CAGR over the forecast period, owing to improvising healthcare infrastructure and increasing demand for minimally invasive diagnostic tools in countries in this region.
Global Allergy Diagnostics and Therapeutics Market Segmentation:
Segmentation by product:
Segmentation by allergen type:
Segmentation by test type:
- In vivo Test
- Skin Prick Test
- Intradermal Test
- Patch Test
- In vitro Test
Segmentation by drug class:
- Mast Cell Stabilizers
- Leukotriene Inhibitors
- Nasal Anticholinergics
- Autoinjectable Epinephrine
Segmentation by end user:
- Diagnostic Laboratories
- Academic Research Institutes
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2019 Estimated Year 2020 Forecast Period 2020–2029 Revenue in US$
- Thermo Fisher Scientific Inc.
- Omega Diagnostics GmbH
- Siemens Healthcare GmbH
- Stallergenes Greer PLC
- Lincoln Diagnostics Inc.
- bioMérieux S.A.
- HOB Biotech Group Co., Ltd.
- Alcon Laboratories, Inc.
- Hycor Biomedical Inc.
- Hitachi Chemical Diagnostics, Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!